A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD AE Renton, E Majounie, A Waite, J Simón-Sánchez, S Rollinson, ... Neuron 72 (2), 257-268, 2011 | 4750 | 2011 |
Amyotrophic lateral sclerosis O Hardiman, A Al-Chalabi, A Chio, EM Corr, G Logroscino, W Robberecht, ... Nature reviews Disease primers 3 (1), 1-19, 2017 | 1834 | 2017 |
State of play in amyotrophic lateral sclerosis genetics AE Renton, A Chiò, BJ Traynor Nature neuroscience 17 (1), 17-23, 2014 | 1773 | 2014 |
Exome sequencing reveals VCP mutations as a cause of familial ALS JO Johnson, J Mandrioli, M Benatar, Y Abramzon, VM Van Deerlin, ... Neuron 68 (5), 857-864, 2010 | 1443 | 2010 |
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study E Majounie, AE Renton, K Mok, EGP Dopper, A Waite, S Rollinson, ... The Lancet Neurology 11 (4), 323-330, 2012 | 1335 | 2012 |
Amyotrophic lateral sclerosis MA Van Es, O Hardiman, A Chio, A Al-Chalabi, RJ Pasterkamp, ... The Lancet 390 (10107), 2084-2098, 2017 | 1190 | 2017 |
Prognostic factors in ALS: a critical review A Chio, G Logroscino, O Hardiman, R Swingler, D Mitchell, E Beghi, ... Amyotrophic lateral sclerosis 10 (5-6), 310-323, 2009 | 1168 | 2009 |
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis: European journal of neurology 19 (3), 360-375, 2012 | 1102 | 2012 |
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature A Chiò, G Logroscino, BJ Traynor, J Collins, JC Simeone, LA Goldstein, ... Neuroepidemiology 41 (2), 118-130, 2013 | 1045 | 2013 |
Incidence of amyotrophic lateral sclerosis in Europe G Logroscino, BJ Traynor, O Hardiman, A Chiò, D Mitchell, RJ Swingler, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (4), 385-390, 2010 | 1045 | 2010 |
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players A Chio, G Benzi, M Dossena, R Mutani, G Mora Brain 128 (3), 472-476, 2005 | 640 | 2005 |
Controversies and priorities in amyotrophic lateral sclerosis MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ... The Lancet Neurology 12 (3), 310-322, 2013 | 631 | 2013 |
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study A Chiò, A Calvo, C Moglia, L Mazzini, G Mora Journal of Neurology, Neurosurgery & Psychiatry 82 (7), 740-746, 2011 | 614 | 2011 |
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 600 | 2016 |
Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 596 | 2018 |
Prognosis in amyotrophic lateral sclerosis: a population-based study MA Del Aguila, WT Longstreth, V McGuire, TD Koepsell, G Van Belle Neurology 60 (5), 813-819, 2003 | 575 | 2003 |
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications R Chia, A Chiò, BJ Traynor The Lancet Neurology 17 (1), 94-102, 2018 | 545 | 2018 |
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis JO Johnson, EP Pioro, A Boehringer, R Chia, H Feit, AE Renton, ... Nature neuroscience 17 (5), 664-666, 2014 | 525 | 2014 |
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040 KC Arthur, A Calvo, TR Price, JT Geiger, A Chio, BJ Traynor Nature communications 7 (1), 12408, 2016 | 458 | 2016 |
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018 | 447 | 2018 |